EPSTEIN–BARR VIRUS IN THE POPULATION OF TWO GEOGRAPHICALLY DIFFERENT REGIONS OF RUSSIA

EPSTEIN–BARR VIRUS IN THE POPULATION OF TWO GEOGRAPHICALLY DIFFERENT REGIONS OF RUSSIA

It is well known that the Epstein–Barr virus (EBV) being widely spread in the human population is also the etiologic agent for a number of malignancies. A notable feature of tumors associated with EBV is their different incidence in various geographical regions, that, as suggested, related with muta...

Full description

Bibliographic Details
Main Authors:	N. B. Senyuta, A. V. Ignatova, M. V. Lomaya, E. V. Goncharova, L. N. Scherback, T. E. Dushenkina, D. V. Gugunov, A. M. Mudunov, V. E. Gurtsevitch
Format:	Article
Language:	Russian
Published:	Sankt-Peterburg : NIIÈM imeni Pastera 2017-03-01
Series:	Инфекция и иммунитет
Subjects:	epstein–barr virus antibody response nasopharyngeal cancer lmp1 oncogene
Online Access:	https://www.iimmun.ru/iimm/article/view/478

Similar Items

EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA: VIRAL MARKERS FOR DIAGNOSTICS AND ASSESSMENT OF CLINICAL STATUS OF PATIENTS
by: V. N. Kondratova, et al.
Published: (2018-04-01)

Molecular biological properties of the Эpstein-Barr virus LMP1 gene: structure, function and polymorphism
by: K. V. Smirnova, et al.
Published: (2015-06-01)

Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
by: Xintong Peng, et al.
Published: (2021-08-01)

Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma
by: Tomokazu Yoshizaki, et al.
Published: (2023-12-01)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
by: Naveed Ahmed, et al.
Published: (2022-12-01)

Diagnostic value of the Epstein-Barr virus serological markers in patients with nasopharyngeal carcinoma in cases of undetectable primary tumor location
by: V. E. Gurtsevitch, et al.
Published: (2016-10-01)

Phylodynamic characteristics of the LMP-1 gene of the Epstein–Barr virus isolated in the Nizhny Novgorod region
by: Daria A. Bryzgalova, et al.
Published: (2023-11-01)

Epstein–Barr virus LMP1 oncogene polymorphism in tatar and slavic populations in Russian Federation impacting on some malignant tumours
by: V. E. Gurtsevitch, et al.
Published: (2020-05-01)

New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma
by: Kathy H. Y. Shair, et al.
Published: (2018-03-01)

Epstein–Barr virus <i>(Herpesviridae: Gammaherpesvirinae: Lymphocryptovirus: Human gammaherpesvirus 4)</i> in Kalmyks and Slavs living in Russia: virus types, <i>LMP1</i> oncogene variants, and malignancies
by: Vladimir E. Gurtsevitch, et al.
Published: (2022-09-01)

Spatial Dispersal of Epstein–Barr Virus in South America Reveals an African American Variant in Brazilian Lymphomas
by: Paula Alves, et al.
Published: (2022-08-01)

Update of Natural Products and Their Derivatives Targeting Epstein–Barr Infection
by: Rosamaria Pennisi, et al.
Published: (2024-01-01)

THE MODERN CONCEPTIONS ABOUT IMMUNOPATHOGENESIS OF INFECTION CAUSED BY THE EPSTEIN–BARR VIRUS
by: T. V. Goreiko, et al.
Published: (2014-06-01)

Do Epstein–Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?
by: Paul J. Farrell, et al.
Published: (2021-12-01)

Distribution of Epstein–Barr Virus LMP1 Variants in Patients with Infectious Mononucleosis and Association with Selected Biochemical and Hematological Parameters
by: Snjezana Zidovec-Lepej, et al.
Published: (2023-07-01)

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
by: Saidu Kamara, et al.
Published: (2023-06-01)

Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein–Barr Virus Infection
by: Xue Liu, et al.
Published: (2022-08-01)

Epstein–Barr virus (Herpesviridae: <i>Lymphocryptovirus</i>) types 1 and 2 and other viral markers in patients with nasopharyngeal carcinoma in two geographically and ethnically distinct regions of Russia
by: Ksenia V. Smirnova, et al.
Published: (2023-09-01)

Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China
by: Ting Hu, et al.
Published: (2019-05-01)

Genetic diversity of the Epstein–Barr virus: a modern view of the problem
by: M. I. Popkova, et al.
Published: (2022-03-01)

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein–Barr Virus LMP1 Protein
by: Abdelhalim Khenchouche, et al.
Published: (2023-06-01)

Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (<i>Herpesviridae</i>, <i>Lymphocryptovirus</i>, HHV-4) serological and molecular markers in cases of undetected primary tumor location
by: N. B. Senyuta, et al.
Published: (2019-10-01)

The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration
by: Hannah E. Bridgewater, et al.
Published: (2020-07-01)

Long-Term Outcomes of Nasopharyngeal Carcinoma by Epstein–Barr Virus Status in the Chinese Population: A Multicenter Investigation
by: Yudi Xiong, et al.
Published: (2023-04-01)

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
by: Chin King Looi, et al.
Published: (2021-04-01)

Epstein–Barr virus (Orthoherpesviridae: <i>Lymphocryptovirus</i>) among Russian ethnic groups: Prevalence of EBV types (EBV-1 and EBV-2), <i>LMP1</i> gene variants and malignancies
by: Vladimir E. Gurtsevitch, et al.
Published: (2024-03-01)

Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana
by: Richmond Ayee, et al.
Published: (2020-07-01)

PRESENCIA DEL MARCADOR LMP-1 DEL VIRUS EPSTEIN-BARR EN LINFOMAS DE CANINOS
by: L. C. Veloza, et al.
Published: (2017-01-01)

Arginine Methyltransferases Are Regulated by Epstein-Barr Virus in B Cells and Are Differentially Expressed in Hodgkin’s Lymphoma
by: Sarah Leonard, et al.
Published: (2012-09-01)

DETECTION OF EPSTEIN-BARR VIRUS GENOME IN ORAL CAVITY SQUAMOUS CELL CARCINOMA SAMPLES OF RUSSIAN PATIENTS
by: S. A. Kiryanov, et al.
Published: (2019-06-01)

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
by: Chung-Chun Wu, et al.
Published: (2018-04-01)

Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Hua Zheng, et al.
Published: (2023-07-01)

Ancient variants of the Epstein–Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4): hypotheses and facts
by: Kseniya V. Smirnova, et al.
Published: (2020-05-01)

Epstein–Barr Virus Infection of Pseudostratified Nasopharyngeal Epithelium Disrupts Epithelial Integrity
by: Fenggang Yu, et al.
Published: (2020-09-01)

Associations between environmental factors and serological Epstein‐Barr virus antibodies in patients with nasopharyngeal carcinoma in South China
by: Ting Zhou, et al.
Published: (2019-08-01)

The Dietary Flavonol Kaempferol Inhibits Epstein–Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells
by: Chung-Chun Wu, et al.
Published: (2022-11-01)

Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts
by: Po-Ju Lee, et al.
Published: (2022-08-01)

Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma
by: Shuting Wu, et al.
Published: (2023-12-01)

Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinomaResearch in context
by: Harue Mizokami, et al.
Published: (2024-04-01)

Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: Study design, methods and feasibility
by: Guo Xiu, et al.
Published: (2006-06-01)